$CME

CME Group 3Q 2026: Revenue $1.74B, EPS $2.89— 10-Q Summary

CME Group reported Q3 2026 revenue of $1.74B, up 13% YoY, with net income rising 14% to $1.04B and EPS increasing 16% to $2.89. Growth was driven by higher trading activity and market data revenue, while average daily volume increased 16%.

Original reporting
Published Oct 23, 2026, 6:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 6:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CME Group 3Q 2026: Revenue $1.74B, EPS $2.89— 10-Q Summary — source image
Decision brief

The 30-second read

$CMEBullishHigh
01

Why it matters

The 13% revenue growth and 16% EPS increase signal continued demand for derivatives trading and data services, supporting a bullish outlook for the stock.

02

Market read

Earnings beat from a large‑cap exchange operator is a high‑impact catalyst for equity markets and related financial‑services stocks.

03

What to watch

Increasing technology support costs from the Google Cloud migration could pressure margins in future quarters.

Relevance 9/10Novelty 9/10Timing: after-hours

Background

CME Group is the world’s largest derivatives exchange, providing futures and options clearing, market data, and technology services.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

CME Group reported Q3 2026 revenue of $1.74B, net income $1.04B and EPS $2.89, all up double‑digits YoY.

Expected impact

likely upward pressure as the market prices in the revenue and earnings beat

Evidence & confidence

Revenue and EPS both rose >13% YoY, indicating robust trading activity and market‑data demand.

Market effects

Higher trading volumes boost brokerage and data‑provider revenues across the financial services sector.

U.S. market participants may see a modest rally in related exchange‑traded products.

CME's global clearing footprint means the earnings beat could lift sentiment for other derivatives exchanges worldwide.

Counterpoint

If the market had already priced in strong activity, the earnings surprise may be muted and the stock could face short‑term profit‑taking.

Key entities

  • CME Group Inc.

    Global derivatives exchange reporting Q3 2026 results.

Related articles

$CMEMedAI 9/10

Key facts: CME Q3 Up; Adds BCH & UNI Futures; Crypto Revenue Embedded

CME Group (CME) reported Q3 2026 revenue of $1.74B (+13%), net income of $1.04B, and diluted EPS of $2.89 (+16%). The company launched Bitcoin Cash and Uniswap futures on Oct 19, 2026, and noted record average daily volume. Crypto revenue is embedded within broader market activities. CME also highlighted regional copper pricing divergences and 24/7 crypto trading volumes.

$CMEMedAI 8/10

CME Posts Record Q3 Revenue As Crypto Derivatives Push Continues

CME Group reported record Q3 revenue of $1.74B, up 13% YoY, with average daily volume at 29.4M contracts. Market-data revenue reached $243M. The company expanded its crypto offerings, announcing Bitcoin Cash and Uniswap futures, but did not disclose crypto-specific revenue. According to CME, first-half crypto derivatives volume averaged 279,800 contracts, with $8.3B in notional value.

$CMEMed

CME Maintained by Barclays -- Price Target Raised to $321

Barclays maintained an Equal-Weight rating on CME Group (CME) but raised its price target to $321 from $281. CME's stock is currently priced at $305.65, which is 10.8% overvalued according to its GF Value™ of $275.98. The company has a GF Score™ of 88/100, indicating strong performance in profitability and growth. 19 gurus hold CME, with 12 adding to their positions recently.

$CMEMed

CME Maintained by Wells Fargo -- Price Target Raised to $333

Wells Fargo maintained an Overweight rating for CME Group and raised its price target to $333 from $315. CME operates the world's largest derivatives marketplace. GuruFocus values CME at $275.98, indicating a 10.9% overvaluation at its current price of $306.07. The company has a GF Score of 88, with strong growth and profitability metrics.